Results 101 to 110 of about 40,966,695 (254)

Comparison of dose parameters to the organs at risk.

open access: yes, 2013
Organs at risk: a) Esophagus, b) heart, c) major airway, d) major vessels, e) spinal cord, f) and g) mean lung dose (MLD) and V20 for the total lung, after normalized to the absolute dose constraints between helical tomotherapy (Tomo), 2-arc, and 8-arc ...
Guishan Fu (400071)   +9 more
core   +1 more source

Pathways and pitfalls: a qualitative study of student experiences in biomedical science education

open access: yesFEBS Open Bio, EarlyView.
Biomedical science students from underrepresented backgrounds face barriers including financial strain, disrupted laboratory access and cultural exclusion. Peer networks provide vital support when institutional systems are difficult to navigate. To create inclusive learning environments and achieve academic success, educators should blend active, hands‐
Olivia J. Russell   +8 more
wiley   +1 more source

Dosimetric Evaluation of Two LINAC-Based Stereotactic Radiosurgery Approaches in the Management of Single Brain Metastasis [PDF]

open access: yesMiddle East Journal of Cancer
Background: Stereotactic radiosurgery (SRS) relies on precise, highly conformal radiation with sharp dose falloff to protect adjacent normal brain tissue.
Srikanth Guduru   +4 more
doaj   +1 more source

In silico and in vitro exploration of a tyrosinase for biocatalytic production of catechols

open access: yesFEBS Open Bio, EarlyView.
Tyrosinase from Ralstonia pseudosolanacearum is a promising biocatalyst for producing valuable catechols from monophenol substrates. This tyrosinase is uniquely suited to this due to its high monophenolase : diphenolase ratio. We combined in silico docking and in vivo kinetic characterisation of this tyrosinase with 11 industrially relevant monophenols,
James Britton   +6 more
wiley   +1 more source

Dosimetric results for organs at risk (OARs) (X¯±s).

open access: yes, 2015
P1: 1A vs. c-IMRT P2: 2A vs. c-IMRT P3: 2A vs.1A P4: 3A vs.2A P5: 3A vs. c-IMRTDosimetric results for organs at risk (OARs) (X¯±s).
Tian-Tian Zhai (713774)   +6 more
core   +1 more source

Cell surface CD11c as a neutrophil aging marker molecule

open access: yesFEBS Open Bio, EarlyView.
Cell surface CD11chi neutrophils were more aged and had better phagocytic function than CD11c−/lo neutrophils. Transcriptomic analysis of CD11chi neutrophils and CD11c−/lo neutrophils in pediatric population showed that the most difference was seen in infants.
Sophia Koutsogiannaki   +5 more
wiley   +1 more source

Analyzing the Relationship between Dose and Geometric Agreement Metrics for Auto-Contouring in Head and Neck Normal Tissues

open access: yesDiagnostics
This study aimed to determine the relationship between geometric and dosimetric agreement metrics in head and neck (H&N) cancer radiotherapy plans. A total 287 plans were retrospectively analyzed, comparing auto-contoured and clinically used contours ...
Barbara Marquez   +12 more
doaj   +1 more source

In vitro generation of regulatory T cells: A challenging tool for studying immune aging in humans

open access: yesFEBS Open Bio, EarlyView.
In vitro induction of human regulatory T cells using standard protocols generates suppressive, Foxp3‐expressing CD4+ T cells independently of TGF‐β supplementation and donor age. Regulatory T (Treg) cells play a key role in immune tolerance and homeostasis.
Lynn Muller   +3 more
wiley   +1 more source

Challenges of quantitative microbial risk assessment at EU level. [PDF]

open access: yes, 2009
Quantitative microbial risk assessment (QMRA) aims to model the fate of pathogenic micro-organisms along the food chain and the associated health risks.
Evers, E.G.   +4 more
core  

Proton therapy for breast cancer: Reducing toxicity

open access: yesThoracic Cancer
Radiotherapy is a crucial component in the holistic management of breast cancer, with approximately 60% of individuals diagnosed with breast cancer requiring this treatment.
Kailin Qiao   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy